This type of sugar test, is the easiest and fastest test you can do sugar. And less expensive than the rest of the other tests.
It requires a single drop of blood from the finger and put blood on a special bar with sugar and put in the sugar measuring device to determine the level of sugar in the blood.
If measuring more than 126 mg / dl (mg / dl ) Must do another test sugar, for example: test after the fasting period.
For diabetics, especially for type 1 diabetics, one of the aspects that they find most annoying is having to prick your finger three to five times a day to measure your blood glucose level. In various studies on the quality of life of patients, they have placed punctures as more annoying than applying insulin.
Therefore, the appearance on the market of a new device that can measure glucose without punctures means a paradigm shift in the treatment of type 1 diabetes, and also for type 2 diabetics who receive insulin and glucose should be measured regularly .
In the management of diabetes, the patient's role is key and in turn, most patients do not achieve adequate glucose levels: 60% of diabetics do not meet the recommended blood glucose goals. Is that, to achieve this, measurement and monitoring is essential. However, it is estimated that 4 out of 10 diabetics do not do it frequently.
The new device, called Abbott's FreeStyle Libre, is made up of a small sensor, about the size of a 2-peso coin that is placed in the arm and measures glucose in interstitial fluid using a filament that is placed under the skin and stays in place attached to a small adhesive patch. That patch has a shelf life of 14 days, in which the patient can wet it, play sports, and any normal activity without risk of going out. On the other hand is the reader (an electronic device, similar to a small cell phone) that, when approached to the sensor, scans the glucose level in less than a second. And it works even if the person has several layers of clothing that cover it. The patch with the sensor is placed on the back of the arm, because in the tests it was determined that this was the place of the body that the device was least at risk of engaging with a door or being accidentally removed.
Currently, in order to have a good control of the disease, type 1 diabetics should be applied between 4 and 6 injections a day and make between 3 and 5 digital punctures daily. "This alters the quality of life of any person," says Dr. Leon Litwak, of the Diabetes and Metabolism section of the Italian Hospital. And he warns that this new system is a paradigm shift because the device "gives a dynamic aspect to monitoring, which is what the pancreas naturally does," he says. It is that the device keeps the information of each measurement (it needs a minimum of three per day and can register up to 80 in one day) and it sets the trend. This allows to see if there is a tendency to hyper or hypogulucemia, and that the patient can act accordingly.
“My daughter is 22 years old today and has been diagnosed with type 1 diabetes since she was two years old. I would have been fascinated not to have to prick his fingers. Undoubtedly, it is a great advance, which we hope will be available for all patients with diabetes, and not only for those who can afford it, ”said ClarÃn Liliana Tieri, director and founder of the Association for Diabetes Care in Argentina , who works with children. The new device is approved for children from 4 years.
“In the case of children it is an impressive advance. Giving parents the ability to pass the reader through the sensor without the need to wake the boy to prick it is a very important step, ”agrees Dr. Graciela Fuentes, head of the Diabetes service at Durand Hospital and vice president of the Argentine Diabetes Society.
Although the device is already in Argentina, the Abbott laboratory is still in talks with the different actors in the health system so that it has coverage. At the moment it will be possible to acquire in particular, for a value of 1,100 pesos the reader (which is acquired only once) and 1,100 pesos the sensor that lasts 14 days. The laboratory is negotiating with a pharmacy to handle its marketing, with the possibility of shipping throughout the country.
Diabetes in Argentina has a prevalence of 9.8% in people over 18 years. And it is estimated that there are 300 thousand type 1 diabetics in the country. However, diabetes is a worldwide epidemic, affecting 382 million people in the world. And it is estimated that by 2035 the figure will increase by 20%.
For diabetics, especially for type 1 diabetics, one of the aspects that they find most annoying is having to prick your finger three to five times a day to measure your blood glucose level. In various studies on the quality of life of patients, they have placed punctures as more annoying than applying insulin.
Therefore, the appearance on the market of a new device that can measure glucose without punctures means a paradigm shift in the treatment of type 1 diabetes, and also for type 2 diabetics who receive insulin and glucose should be measured regularly .
In the management of diabetes, the patient's role is key and in turn, most patients do not achieve adequate glucose levels: 60% of diabetics do not meet the recommended blood glucose goals. Is that, to achieve this, measurement and monitoring is essential. However, it is estimated that 4 out of 10 diabetics do not do it frequently.
The new device, called Abbott's FreeStyle Libre, is made up of a small sensor, about the size of a 2-peso coin that is placed in the arm and measures glucose in interstitial fluid using a filament that is placed under the skin and stays in place attached to a small adhesive patch. That patch has a shelf life of 14 days, in which the patient can wet it, play sports, and any normal activity without risk of going out. On the other hand is the reader (an electronic device, similar to a small cell phone) that, when approached to the sensor, scans the glucose level in less than a second. And it works even if the person has several layers of clothing that cover it. The patch with the sensor is placed on the back of the arm, because in the tests it was determined that this was the place of the body that the device was least at risk of engaging with a door or being accidentally removed.
Currently, in order to have a good control of the disease, type 1 diabetics should be applied between 4 and 6 injections a day and make between 3 and 5 digital punctures daily. "This alters the quality of life of any person," says Dr. Leon Litwak, of the Diabetes and Metabolism section of the Italian Hospital. And he warns that this new system is a paradigm shift because the device "gives a dynamic aspect to monitoring, which is what the pancreas naturally does," he says. It is that the device keeps the information of each measurement (it needs a minimum of three per day and can register up to 80 in one day) and it sets the trend. This allows to see if there is a tendency to hyper or hypogulucemia, and that the patient can act accordingly.
“My daughter is 22 years old today and has been diagnosed with type 1 diabetes since she was two years old. I would have been fascinated not to have to prick his fingers. Undoubtedly, it is a great advance, which we hope will be available for all patients with diabetes, and not only for those who can afford it, ”said ClarÃn Liliana Tieri, director and founder of the Association for Diabetes Care in Argentina , who works with children. The new device is approved for children from 4 years.
“In the case of children it is an impressive advance. Giving parents the ability to pass the reader through the sensor without the need to wake the boy to prick it is a very important step, ”agrees Dr. Graciela Fuentes, head of the Diabetes service at Durand Hospital and vice president of the Argentine Diabetes Society.
Although the device is already in Argentina, the Abbott laboratory is still in talks with the different actors in the health system so that it has coverage. At the moment it will be possible to acquire in particular, for a value of 1,100 pesos the reader (which is acquired only once) and 1,100 pesos the sensor that lasts 14 days. The laboratory is negotiating with a pharmacy to handle its marketing, with the possibility of shipping throughout the country.
Diabetes in Argentina has a prevalence of 9.8% in people over 18 years. And it is estimated that there are 300 thousand type 1 diabetics in the country. However, diabetes is a worldwide epidemic, affecting 382 million people in the world. And it is estimated that by 2035 the figure will increase by 20%.
Labels
analysis of diabetes